Systemic Scleroderma
Denny L. Tuffanelli · Archives of Dermatology · 1961
Scleroderma was described centuries ago, and yet today the physician has little to offer other than the diagnosis. The etiology remains obscure; the course is unpredictable, and therapy is of little benefit. The term "scleroderma" is limited, for literally it means merely "hard skin." Under this label are included disease processes varying from the sclerosis of a bit of skin to overwhelming systemic reactions terminating in rapid death. While innumerable case reports and reviews of scleroderma have appeared in the literature, we believed that a longterm clinical study, unique in the extremely large number of patients observed, would add to our knowledge of a poorly understood entity. Classification The classification of scleroderma used in the Section of Dermatology at the Mayo Clinic is as follows: Localized Morphea Generalized morphea Linear scleroderma En coup de sabre Hemiatrophy Systemic Acrosclerosis Diffuse scleroderma In this paper we will be concerned only with the
Cited by 531 works. doi:10.1001/archderm.1961.01580150005001
Authors
References
- SCLERODERMA (BASED ON A STUDY OF OVER 150 CASES)
- Progressive Systemic Sclerosis (Scleroderma)
- Progressive Systemic Sclerosis
- Prognostic Significance of Raynaud's Phenomenon and Other Clinical Characteristics of Systemic Scleroderma
- A characteristic dental finding in acrosclerosis and diffuse scleroderma
- THE DIAGNOSIS AND TREATMENT OF SCLERODERMA AND ACROSCLEROSIS, AND SOME OF THEIR KINDRED DISEASES
- Calcinosis Cutis: Its Relationship to Scleroderma
- Systemic Scleroderma with Portal Hypertension
- DERMATOFIBROSIS LENTICULARIS DISSEMINATA AND OSTEOPOIKILOSIS
- Scleroderma of the Small Intestine